{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (continuing ops)",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.99 vs. cons $2.00",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic Sales Growth (Q2)",
      "prediction": "MISS",
      "answer": "pred ~1.0% vs. cons ~1.8%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted Gross Margin (yoy bps change)",
      "prediction": "MISS",
      "answer": "pred ~-30bps vs. cons ~+40bps",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 Organic Sales Growth guidance",
      "prediction": "LOWER",
      "answer": "guide ~2.0% vs. cons ~2.5% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Adjusted Operating Profit Growth (constant currency)",
      "prediction": "LOWER",
      "answer": "guide ~4% vs. cons ~6% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "H2 2026 incremental input-cost headwind (oil/geopolitical)",
      "prediction": "LOWER",
      "answer": "guide ~$150-170M vs. cons ~$0 baked in (H2 2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.7,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.2,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Q2 results likely show EPS roughly in-line but organic growth missing on a tough comp plus the DC-fire drag, while margins slip further on the flagged Middle East/oil-driven input cost hit; if management flags an incremental $150-170M H2 cost headwind without fully offsetting mitigation, sell-side models will need to trim FY organic growth and operating profit growth assumptions even after any narrow EPS beat, and lingering uncertainty on Kenvue close timing/financing removes a re-rating catalyst that could otherwise cushion the stock, arguing for continued downward drift over the week rather than a snapback.",
  "day5_confidence": "LOW"
}